Evidence map›Paper›PMID 29751015›Full record

ArticleJournal of molecular biology2018

Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase.

Tatiana V Ilina, Ryan L Slack, John H Elder, Stefan G Sarafianos, Michael A Parniak, Rieko Ishima

Abstract read
In one paragraph

Article in Journal of molecular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Tatiana V IlinaDepartment of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, United States; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, United States.
Ryan L SlackDepartment of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, United States.
John H ElderDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, United States.
Stefan G SarafianosLaboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, United States.
Michael A ParniakDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, United States.
Rieko IshimaDepartment of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, United States. Electronic address: ishima@pitt.edu.
University of Pittsburgh · USEmory University · USScripps Research Institute · US

Funding

Project 9P50GM103368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SHARPLESS, KARL BARRY · 2012 to 2016
$20.0M
X-ray Crystallographic Fragment Screening CoreU54AI150472 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI TORBETT, BRUCE EDWARD · 2019 to 2021
$15.7M
X-ray Crystallographic Fragment Screening CoreU54GM103368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI TORBETT, BRUCE EDWARD · 2017 to 2018
$11.1M
Tracking the evolution of drug resistance for highly potent HIV protease inhibitoP01GM109767 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SHERMAN, BRIAN WOODY · 2014 to 2018
$8.0M
Novel antivirals targeting the RNase H activity of HIV reverse transcriptaseR01AI100890 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI SARAFIANOS, STEFAN G, WANG, ZHENGQIANG · 2012 to 2016
$3.6M
Conformational Dynamics and inhibitor responses of HIV-1 RT RNase H in solutionR01GM105401 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ISHIMA, RIEKO · 2013 to 2016
$1.4M
Fibrosis/Tissue Remodeling In Models Of Allergic DiseaseZ01AI000890 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI KEANE-MYERS, ANDREA M · 2001 to 2007
$254k
Intramural NIH HHS Z01 AI000890NIAID NIH HHS R01 AI100890NIGMS NIH HHS P01 GM109767NIGMS NIH HHS P50 GM103368NIGMS NIH HHS R01 GM105401NIGMS NIH HHS U54 GM103368
6 · The paper itself

Abstract

The mature HIV-1 reverse transcriptase is a heterodimer that comprises 66 kDa (p66) and 51 kDa (p51) subunits. The latter is formed by HIV-1 protease-catalyzed removal of a C-terminal ribonuclease H domain from a p66 subunit. This proteolytic processing is a critical step in virus maturation and essential for viral infectivity. Here, we report that tRNA significantly enhances in vitro processing even at a substoichiometric tRNA:p66/p66 ratio. Other double-stranded RNAs have considerably less pronounced effect. Our data support a model where interaction of p66/p66 with tRNA introduces conformational asymmetry in the two subunits, permitting specific proteolytic processing of one p66 to provide the mature RT p66/p51 heterodimer.

Indexed as

HIV-1HIV Reverse TranscriptaseModels, MolecularProtein ConformationProtein MultimerizationProteolysisRibonuclease HRNA, TransferRNA, ViralHIV Reverse Transcriptasereverse transcriptase, Human immunodeficiency virus 1Ribonuclease HRNA, TransferRNA, ViralHIV-1maturationproteolysisreverse transcriptaseRNase HtRNA

Identifiers

PMID29751015
PMCPMC5988984
OpenAlexW2799883635

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.